Solid Biosciences Inc. - Common Stock, $0.001 par value per share (SLDB) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2018 to Q4 2025

Type / Class
Equity / Common Stock, $0.001 par value per share
Symbol
SLDB on Nasdaq
Shares outstanding
79,218,487
Price per share
$5.64
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
1,107
Total reported value
$6,243
% of total 13F portfolios
0%
Share change
-11,123
Value change
-$62,723
Number of holders
4
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Solid Biosciences Inc. - Common Stock, $0.001 par value per share (SLDB) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RA CAPITAL MANAGEMENT, L.P. 9.9% $3,595,419 7,989,820 RA Capital Management, L.P. 19 Feb 2025
BCLS SB Investco, LP 7.8% $237,897 6,179,042 BCLS II Investco, LP 19 Feb 2025

As of 31 Dec 2025, 4 institutional investors reported holding 1,107 shares of Solid Biosciences Inc. - Common Stock, $0.001 par value per share (SLDB). This represents 0% of the company’s total 79,218,487 outstanding shares.

Institutional Holders of Solid Biosciences Inc. - Common Stock, $0.001 par value per share (SLDB) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 1,107 $6,243 -$62,723 $5.64 4
2025 Q3 12,230 $75,459 +$70,936 $6.17 4
2025 Q2 733 $3,569 +$1,352 $4.87 3
2025 Q1 478 $1,769 +$1,743 $3.71 3
2024 Q4 7 $28 $4.00 1
2024 Q3 7 $49 $7.00 1
2024 Q2 7 $40 +$6 $5.71 1
2024 Q1 6 $80 $13.33 1
2023 Q4 6 $37 $6.17 1
2023 Q3 6 $15 -$346 $2.50 1
2023 Q2 72 $377 $5.20 2
2023 Q1 72 $341 -$57,791 $4.70 2
2022 Q4 10,806 $58,136 -$29,139,216 $5.36 2
2022 Q3 62,916,116 $29,199,793 +$794,183 $0.47 49
2022 Q2 64,213,719 $39,529,533 -$5,527,398 $0.62 56
2022 Q1 69,295,383 $83,158,688 -$8,045,281 $1.20 73
2021 Q4 75,541,107 $132,178,834 -$5,128,947 $1.75 78
2021 Q3 76,975,796 $184,313,421 -$8,372,053 $2.39 86
2021 Q2 80,038,410 $292,936,775 +$60,718 $3.66 86
2021 Q1 79,131,292 $437,590,934 +$134,289,421 $5.53 103
2020 Q4 54,604,305 $413,863,843 +$230,271,907 $7.58 75
2020 Q3 25,431,070 $51,626,219 -$3,132,877 $2.03 55
2020 Q2 26,709,659 $78,256,131 +$21,247,711 $2.93 65
2020 Q1 19,636,888 $46,931,304 -$1,346,208 $2.39 70
2019 Q4 19,881,433 $88,468,790 -$123,259,144 $4.45 67
2019 Q3 32,117,446 $332,091,673 +$95,994,970 $10.34 69
2019 Q2 18,570,664 $106,695,745 +$20,118,478 $5.75 71
2019 Q1 17,113,127 $157,446,313 -$213,488,146 $9.20 74
2018 Q4 24,190,736 $648,312,427 +$128,327,742 $26.80 74
2018 Q3 18,605,082 $877,772,812 +$64,671,762 $47.18 76
2018 Q2 15,341,932 $545,311,685 +$93,312,873 $35.63 63
2018 Q1 15,597,572 $116,521,712 +$116,521,712 $7.50 55